SlideShare a Scribd company logo
Perioperative infection control and
wound healing: Role of
anesthesiologist
Moderator
Dr. Nishkarsh Gupta Dr. Hitender Gautam
Additional Professor Associate Professor
Deptt. of OAPM Deptt. of Microbiology
Dr. Brajesh Ratre
Assistant Professor
Deptt. of OAPM
Presenter- Dr. Gitartha Goswami
SR, Deptt. of OAPM
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Highlights
• Epidemiology
• Pathophysiology
• SSIs and Wound infection
• Microbiology
• Risk factors
• Role of anesthesiologists
• Guidelines and evidences
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Epidemiology
• Incidence of HCAI- developed countries- 3.5–12%, developing countries-
5.7%- 19.1%.
• The risk of HCAI in the OR is even higher.
• SSIs- 2nd most common cause of HCAIs after UTI, account for approximately
17% of all HCAI.
• SSIs are the most common perioperative infection, 38% of all infections in
surgical patients
• Prolongs hospital stay, cause morbidity, increase the cost of health care, and
lead to mortality
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Pathophysiology
• Tissue damage leads to the release of damage activated molecular patterns
(DAMPs) or alarmins into the circulation, eg- HMGB 1, mtDNA
• DAMPs activates pattern recognition receptors (PRRs), also independently
activate complement, neutrophils, monocytes and dendritic cells.
• Activation of PRRs → secretion of cytokines and chemokines via signalling
pathways involving NF-kB.
• Excess production of inflammatory mediators (ILs) leads to SIRS.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Pathophysiology
• SIRS is associated with a compensatory increase in anti-inflammatory
cytokines (IL-10, TGF-β).
• The balance of proinflammatory (IL-6, TNF-a) and antiinflammatory factors
dictates whether inflammation return to baseline or progress to persistent
inflammation, immunosuppression, and catabolism syndrome (PICS).
• PICS increases risk of MODS and sepsis.
• Paradoxically, SIRS suppresses body’s ability to mount a defence against
invading pathogens.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Pathophysiology
• Increased susceptibility to infection and sepsis, invading microbes further
stimulate immune cells via pathogen-associated molecular patterns
(PAMPs).
• A vicious cycle ensues, SIRS results in inflammation and immunoparesis,
which, in turn, leads to sepsis with furthur inflammation and risk of MODS.
• The initial complement activation leads to consumption of complement, an
imbalance ensues, rendering the host susceptible to invading pathogens.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Pathophysiology
• The transfusion of blood and products along with anesthetics contribute to
this immunosuppressive environment.
• Anaesthesia suppresses the immune system, both directly and indirectly.
• Cancer recurrence and infection are intimately linked, both flourish in an
environment of T-cell exhaustion and lymphocyte anergy, observed in the
perioperative period.
• The key concern is the creation of a protumour and proinfection cytokine
and inflammatory milieu.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Pathophysiology
• Natural killer cells, are suppressed by both anaesthetics and opioids.
• Anaesthetics mediate secondary effects through altered adrenocortical
function.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
SSIs
• CDC defines SSI- infection related to an operative procedure that occurs at
or near the surgical incision within 30 days of the procedure or within 90
days if prosthetic material is implanted.
• All surgical wounds are likely to become contaminated, usually by resident
bacterial flora.
• May not be significant and contaminated wounds may go unnoticed.
• Progression from wound contamination to clinical infection is determined
by the adequacy of host defence.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
8-10% 12-20% 25%
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
SSIs types
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
SSIs types
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
MICROBIOLOGY
• Pathogens depend upon the type of wound
• Clean procedures- skin flora, including streptococcal
species, Staphylococcus aureus, and CONS.
• Clean-contaminated procedures- gram-negative and enterococci in
addition to skin flora.
• Surgical procedure involves a viscus, the pathogens reflect the
endogenous flora of the viscus or nearby mucosal surface; typically
polymicrobial.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
MICROBIOLOGY
• The causative pathogens associated with SSIs have changed over time.
• SSIs caused by gram-negative bacilli decreased, with emergence MRSA.
• MRSA associated were higher mortality rates, longer hospital stays, and
higher costs.
• During the past decade the proportion of SSI due to MRSA declined.
• Fungal SSIs- widespread use of prophylactic and empiric antibiotics,
increased severity of illness, and immunocompromised patients.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
MICROBIOLOGY
• Exogenous sources of contamination- OR environment or
personnel.
• Anal, vaginal, or nasopharyngeal carrier of group A streptococci by
OR personnel, led to several SSI outbreaks.
• Gram-negative organisms is commonly seen on the hands with
artificial nails.
• Rare outbreaks or clusters of SSIs caused by unusual pathogen-
traced to contaminated dressings, bandages, irrigants, or
disinfection solution
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
RISK FACTORS FOR SSI
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Why cancer patients are at increased risk?
• Effects of Cancer
- Impaired cellular and humoral immunity
- Bone marrow infiltration
• Effects of CT/RT
- Disruption of skin and mucosal barriers
- Neutropenia/impaired neutrophil function
• Functional hyposplenism or asplenia after HSCT
• Poor nutritional status, TPN
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
What is the role of anesthesiolgist?
• Role both outside and inside the OR.
• Infection prevention in the OR anesthesia work area is important
but very challenging owing to the work flow of anesthesia
providers.
• Policies and procedures for HH, safe injection practises, and
environmental cleaning and disinfection.
• Individuals involved in these procedures require training, as well as
regular skills assessments.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Factors controlled by anesthetists
 Hand hygiene
 Aseptic technique during invasive
procedures
 Face masks and sterile barriers
 OR characteristics- Limit traffic
through operating room, Use of
laminar airflow
 Surgical antibiotic prophylaxis
 Glycaemic control
 Perioperative thermoregulation
Perioperative drugs management
 Inspired oxygen concentration
 Perioperative fluid management
 Minimizing blood transfusions
 ERAS
Nutrition
 Anesthetic technique
- Avoidance of selected drugs
- Regional anaesthesia techniques
- Effect of PPV
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Factors controlled by Surgeon and Surgical techniques
1. Skin antisepsis, Hair removal
2. Bowel preparation
3. Gentle traction
4. Effective hemostasis
5. Removal of devitalized tissues
6. Minimization of electrocautery to avoid thermal spread
7. Obliteration of dead space
8. Irrigation of tissues with saline to avoid excessive drying
9. Wound closure without tension
10. Judicious use of closed suction drains
11. Topical and local antibiotic delivery
12. Antibiotic-impregnated implants, antibiotic sutures
13. Wound dressings, wound protectors
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
Guidelines
• Several guidelines available regarding prevention of SSI- CDC, WHO,
APSIC, IDSA, NICE.
• SHEA Expert Guidance on Infection prevention in the operating
room anesthesia work area.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Infection prevention in the OR anesthesia
work area
• Contamination in the anesthesia work area include the anesthesia cart,
stopcocks, LMAs, laryngoscope blades, touchscreens, keyboards,
providers’ hands.
• Anesthesia work area bioburden- both commensal and pathogenic
bacteria, including CONS, Bacillus spp, streptococci, Staph aureus,
Acinetobacter spp etc.
• High risk practises- use of multi-dose vials for >1 patient, <100% use of
gloves during airway management, failure to perform HH after removing
gloves, entry into anesthesia cart drawers without performance of HH.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Hand hygiene
• Ideally performed according to the WHO 5 Moments for Hand Hygiene.
• HH performed- before aseptic tasks, after removing gloves, when hands are
soiled or contaminated, before touching the contents of the anesthesia cart,
and when entering and exiting the OR.
• Indications in the OR can be as high as 54/hr, logistically unfeasible, leading to
non adherence rates of 83%,.
• Increasing access to ABHR led to an increase in HH practises by anesthesiology
staff during a surgical procedure
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Hand hygiene
• ABHR dispensers at the entrances to ORs and near anesthesia providers.
• Double gloves during airway management, removal of outer gloves
immediately after airway manipulation and inner gloves ASAP and
perform HH.
• Current data inadequate to either support or discourage use of ABHR on
gloved hands, application might be better when doffing and donning are
not feasible
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
ASEPTIC PRECAUTIONS FOR VARIOUS
PROCEDURES AND USE OF PPE
• Objective- reduce endogenous and exogenous sources of infection to patients
and HCWs.
• Indications for aseptic practices-
1. During care and nursing of patients : Barrier nursing
2. During therapeutic procedures: i.m. injections, CVP line access, Arterial lines.
3. During airway and endoscopic procedures: Intubation, mechanical
ventilation, suctioning, Bronchoscopy.
4. During various diagnostic procedures
5. Others- foley’s catheterization.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
USE OF PERSONAL PROTECTIVE
EQUIPMENT
• Use of PPE appropriate for the procedure.
• PPE interrupt the chain of transmission of organisms from the patient to the
HCW and from the HCW to the patient.
• Correct donning and doffing practises.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Direct laryngoscope or video-laryngoscope handles and blades should
undergo high-level disinfection or sterilization prior to use.
• Otherwise, replace with single-use ones.
• Clean blades and handles to be stored in packaging appropriate for
semicritical items.
• Infectious disease outbreaks have been associated with contaminated
laryngoscopes.
• Laryngoscope handles not able to undergo high-level disinfection should
not be used.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Inadequate data to make recommendations regarding the use of disposable
covers to prevent contamination of anesthesia machines.
• High-touch surfaces on the anesthesia machine and anesthesia work area
should be disinfected between OR uses.
• Use EPA-approved hospital disinfectant that is compatible with the
equipment and surfaces.
• Reusable monitoring equipment and cables in physical contact with patients
should be cleaned.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• i.v. access ports- disinfected before each use, scrubbing the port with a
sterile alcohol-based disinfectant or use sterile isopropyl alcohol
containing caps to cover ports continuously.
• The act can be challenging in anesthesia practice, particularly during
induction and emergence of anesthesia.
• Maximal sterile barrier precautions- All CVCs and axillary and femoral
arterial lines.
• Other peripheral arterial lines- a minimum of a cap, mask, sterile gloves,
and a small sterile fenestrated drape.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Rubber stoppers of vials and necks of ampules- wiped with 70%
alcohol prior to use.
• Bacterial contamination of medication syringes can occur with skin
microorganisms.
• Needleless syringes should be capped with a sterile cap that
completely covers the Luer connector on the syringe
• Storage of supplies on the top surface of the cart should be
avoided, should be removed between cases to facilitate cleaning.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Provider-prepared sterile injectable drugs should be used as soon as
practicable, USP recommends use within 1hr
• Commercially prefilled syringes or syringes prepared by the hospital
pharmacy have a relatively long life.
• Discard provider-prepared sterile injectable drugs and i.v. solutions at the
end of each case, whether used or not.
• Unused prefilled syringes with intact locks can be returned to stock.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Use Single-dose medication vials and flushes whenever possible.
• Multi-dose vials- used for only 1 patient and accessed with a new sterile
syringe and needle for each entry.
• Syringes and needles are single patient devices and should never be
reused for another patient.
• Both CDC and AAGBI have issued safe injection practices.
• Minimize the time between spiking IV bags and patient administration.
• No specific time limit has been identified in the literature.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR Environmental disinfection
• Computer keyboards and touchscreen- cleaned and disinfected after each
anesthesia case using a hospital-approved disinfectant.
• Use of Plastic keyboard shields, or washable keyboards and touchscreens
facilitate thorough disinfection.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
OR ventilation
• Laminar flow allows particle-free air movement over the aseptic operating
field at a uniform velocity (vertically or horizontally).
• Reduces the burden of microorganisms in the OR during implantation of
prosthetic material
• However, insufficient evidence supporting its routine use
• A systematic review that included 12 observational studies (between 1987
and 2011) did not find any benefit in reducing the incidence of deep
incisional SSI following hip and knee arthroplasty, and abdominal/open
vascular surgeries.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Order of patients
• Common routes for transmission of infection in the OR are airborne or
fomite borne.
• Accurate printed theatre lists to be available prior to the scheduled date.
• ‘Dirty cases’ should be identified beforehand, theatre staffs notified and
scheduled last on an operating list.
• If not possible, Hospital Infection Society advises that a plenum-ventilated
OR should require a minimum of 15 min before proceeding to the next case.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Order of patients
• Appropriate cleaning of the OR between all patients should be
undertaken.
• Visible contamination with blood or body materials disinfected with
sodium hypochlorite and then cleaned with detergent and water.
• Floors of the OR should be disinfected at the end of each session.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Implementation
• Regular monitoring and evaluation of infection prevention
practices.
• Use of measures to improve performance.
• Both overt and covert observation of behaviors can improve
practice.
• Regular feedbacks, surveillance measures.
• Interventions like checklists and simulation for education and
evaluation of different aspects of anesthesia practice
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Surgical antibiotic prophylaxis
CDC WHO IDSA
Timing In a way that bactericidal
concentration of the
agents is established in
the serum and tissues
when the incision is
made
within the 120 min
before the incision,
while considering the
half-life of the
antibiotic (cefazolin,
penicillins)
Within 1 hour,
2 hours for
Vancomycin and
Fluoroquin.
Repeat
doses
No statement At intervals of 2 half-
lives or if there is
excessive blood loss
At intervals of 2
half-lives
• Postoperatively, CDC recommends antibiotic therapy to continue only in
contaminated and dirty cases.
• Antibiotic stewardship programmes should be practised.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Glycaemic control
• Surgery causes a neuroendocrine stress response with release of counter-
regulatory hormones (Epi, glucagon, cortisol, GH).
• Hyperglycaemia increases risk of morbidity and mortality, even in non-
diabetics.
• DM increases susceptibility to infection by altering both the innate and the
adaptive immune systems
• Hyperglycaemia reduces vasodilation, impairs endothelial nitric oxide
generation, decreases complement function, impairs neutrophil
chemotaxis and phagocytosis.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Glycaemic control
• Nonenzymatic glycosylation of Ig, reducing complement fixation and
opsonization of microbes.
• Short-term hyperglycemia increases oxidative stress and systemic
inflammatory responses.
• Also impairs CD8+ T cell mediated immunity.
• Hyperglycaemia alters the critical balance between inflammatory and
antiinflammatory cytokines; increase adverse outcomes.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Glycaemic targets
• CDC guidelines advise perioperative glycemic control, and blood glucose
target levels <200 mg/dL in patients with and without DM to prevent SSIs.
• NICE-SUGAR trial demonstrates conventional glucose control (target of
180 mg/dL) had better outcomes (less mortality) than patients managed
with intensive glucose control (target of 81–108 mg/dL).
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative thermoregulation
• Mild perioperative hypothermia (34°–36°C) is common in surgical patients.
• Heat loss during the first hour of anesthesia- redistribution of core to
peripheral temperature gradients caused by an anesthetic-induced
vasodliation.
• Causes of continued heat loss in the OR are radiation and convection.
• The most effective means of preventing ongoing heat loss are forced air
warming and administration of warmed fluids.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative thermoregulation
• Complications- increased LOS, increased intraoperative blood loss,
transfusion requirements, adverse cardiac events
• Mild hypothermia also increases incidence of SSIs.
• Hypothermia triggers thermoregulatory vasoconstriction, thereby
decreasing subcutaneous tissue oxygen tension
• The major relation between hypothermia and increased SSI.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Preop. temp Management
<36°C Active warming in ward
>/=36°C Active warming at least 30 minutes before induction
Begin induction only when temperature is 36.0°C or above
Active warming throughout the intraoperative phase if-
having anaesthesia for more than 30 minutes or
less than 30 minutes and are at higher risk of inadvertent perioperative
hypothermia
Introp. temp Maintain at >/= 36.5°C
Postop. temp
<36°C Warmed using forced-air warming until comfortably warm
NICE guidelines
SSIs risk with FAW devices
• The waste air from FAW is not simply benign waste air.
• The waste heat and air escapes from under the surgical drape near the
floor, where it warms the contaminated air near the floor.
• The contaminated warm air forms convection currents that rise along the
sides of the surgical table
• It mobilizes the floor bacteria into the sterile surgical field above the
patient.
• Studies have shown mixed results, larger RCTs needed.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative drug management
• Immunosuppressive agents like glucocorticoids, MTX, AZT,
cyclosporine, and tacrolimus.
• Glucocorticoids- major concerns are: (1) the risk of SSIs and (2) the
risk of hemodynamic instability (secondary adrenal insufficiency).
• Ideally, the lowest possible dose of glucocorticoids should be used in
the perioperative setting.
• If patients require >10 mg prednisone (or equivalent) daily, it implies
that the disease activity is not adequately controlled and that elective
surgery should be postponed.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative drug management
• Stopping DMARDs prior to surgery may result in a flare-up of disease
activity, may adversely affect rehabilitation.
• Biologic DMARDs can be continued till day of surgery.
• Non- biologic DMRDs- Stop for atleast 2 weeks each for etanercept
and adalimumab while 6 months for rituximab before elective surgery
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Inspired oxygen concentration
• Postulated to improve the oxidative bactericidal activity of neutrophils.
• Adequate wound PO2 also helps in the development of collagen and
epithelium, instrumental factors in wound healing.
• Evidence that giving 80% FIO2 rather than 30% reduces wound infections
in colorectal surgeries.
• In vitro analysis of neutrophil function reveals that a higher PO2 promotes
the production of reactive oxygen intermediates.
• Current guidelines to prevent SSIs recommend only giving the required
FIO2 to maintain oxygen saturations above 95%.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative fluid management
• Wound healing is critically dependent on adequate perfusion to deliver
oxygen.
• Mild to moderate hypovolemia is well tolerated as interstitial fluid moves
into the intravascular space to preserve cardiac output.
• However, this leaves the subcutaneous tissue relatively hypovolemic.
• The optimal type of fluid (colloid or crystalloid) or strategy of fluid
management (goal directed, liberal, or restrictive) remain controversial.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Perioperative fluid management
• Difficult to assess volume status in both liberal and restrictive strategy
• GDFT has gained evidence for improved outcomes, does not specifically
relate to a reduction in postoperative infection.
• WHO recommednations (2016) on prevention of SSIs- GDFT in intraop.
and postop. period is associated with decreased incidence of SSIs.
• However, restrictive therapy and preoperative GDFT were not associated
with reduction of SSI compared with standard therapy.
• When considering SSIs as endpoint, GDFT may be considered if available.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Minimizing blood transfusions
• Immunomodulation and immunosuppression (TRIM) are known
consequences of allogeneic blood transfusion.
• The incidence of postoperative bacterial infection is higher in
transfused patients.
• This effect is greater in trauma patients- established fact.
• The effect appears to be dose-related, older units (>2weeks)
• Consider risk benefit ratios before transfusion, use fresh units.
• Platelet transfusions are associated with bacterial sepsis.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Enhanced recovery after surgery
(ERAS)
• Initiated by Professor Henrik Kehlet in the 1990s
• ERAS or enhanced recovery programs (ERPs) or fast-tracking.
• Initially started for colorectal surgeries, aim to achieve early
recovery after surgery by maintaining preoperative organ function
and reducing the surgical stress response.
• Implemented in other surgeries and has shown a decrease in the
incidence of HAIs.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
ERAS
• Goals- maintenance of normal physiology in the perioperative period,
decreasing surgical stress.
• Key principles of the ERAS protocol
 pre-operative counselling
 preoperative nutrition
 avoidance of prolonged perioperative fasting and carbohydrate
loading up to 2 hours preoperatively
 standardized anesthetic and analgesic regimens
 early mobilization
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Nutrition
• Malnutrition is associated with a number of negative consequences
 Increased susceptibility to infection
 Poor wound healing
 Increased frequency of decubitus ulcers
 Overgrowth of bacteria in the gastrointestinal tract
 Abnormal nutrient losses through the stool
• Malnutrition leads to immune system dysfunction by impairing
complement activation, bacterial opsonization, and the function of
neutrophils, macrophages, and lymphocytes
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Preoperative nutrition support
• Adequately nourished or mild-to-moderate malnutrition, surgery need not
be delayed for preoperative parenteral or enteral supplementation.
• Patients with severe malnutrition- some benefit from delaying surgery to
be fed only if catabolism is not due to the disease itself.
• Benefit more from enteral than parenteral feeding; TPN increases risk for
infectious complications.
• However, parenteral nutrition was found beneficial in patients with upper
gastrointestinal malignancies and hepatocellular carcinoma.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Postperative nutrition support
• Enteral nutrition (oral or tube feeds) rather than parenteral, whenever
possible.
• Postoperative parenteral nutrition-if return of bowel function is not
anticipated for more than 10 days, severe malnutrition at baseline, or who
have a complicated postoperative course.
• Role for immune-enhancing nutritional supplements(arginine, glutamine,
nonessential fatty acids, branched chain fatty acids), remains unclear.
• There is insufficient high-quality evidence.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Decrease in infectious comlications including pneumonia, sepsis, wound infection,
UTI etc were seen
A 45% reduction on both infectious and non infectious complications were seen.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Anesthetic technique
• Anaesthetic agents
– Iv agents
– Inhalational agents
– Opioids
• The role of Regional anesthesia
• Effect of Positive pressure ventilation.
• Several literature on association of anesthetic technique on cancer
recurrence.
• Perioperative events leading to cancer recurrence may be intimately
related to perioperative infections.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Agent NK cell
no./activity
T-lymphocyte Others
Propofol Increase Do not inhibit Antioxidant effect
Ketamine/
Thiopentone
/ Etomidate
Decrease Decrease T helper cells
Midazolam - - inhibitory efect on innate
immunity,
inhibit neutrophil adhesion by
inhibiting the level of IL-8
Volatile
anesthetics
Decrease Decrease T helper cell
activity
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Agent NK cell
no./activity
T-lymphocyte Others
Morphine suppresses NK
cell activity
Suppresses T-cell
differentiation,
promotes lymphocyte
apoptosis
Inhibit macrophage activity
Fentanyl Decrease Increase regulatory T
cells
Sufentanil Decrease Increase regulatory T
cells
Inhibits leukocyte migration
Tramadol May have protective effects
on cellular immunity
NSAIDs Reverses NK
cell
suppression
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Role of regional anesthesia
• Reduces perioperative stress response.
• Serum levels of the stress hormone cortisol are lower.
• Reducing the need for opioids or volatile anesthetics,
• Orthopedic knee surgery conducted under neuraxial anesthesia led to a
significant lower postoperative infections compared with general
anesthesia.
• A reduced duration of T-cell anergy and disturbances in T lymphocyte
subsets (Th1 and 2)
• However, high-quality evidence is lacking.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
Effect of Positive pressure ventilation
• Positive pressure ventilation appears to impair mucociliary motility in the
airways.
• Stress and shear forces exerted during the cyclic opening and closing of
alveoli result in increased cytokine production and white cell
sequestration, as does over-distension of alveoli
• PPV induce inflammation, decrease surfactant production, VILI.
• May promote translocation of tracheal bacteria into the bloodstream.
• ETT can serve as a conduit between the environment and LRT.
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, National Cancer Institute, AIIMS
Department of Onco-Anaesthesia and Palliative Medicine
IRCH, NCI, AIIMS
perioperative infection control.pptx

More Related Content

Similar to perioperative infection control.pptx

SURGICAL SITE INFECTION (SSI)
SURGICAL SITE INFECTION (SSI)SURGICAL SITE INFECTION (SSI)
SURGICAL SITE INFECTION (SSI)
Ahmed Azmy
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi Sepsis
DoroteaNina1
 
Antibiotic prophylaxis.pptx
Antibiotic prophylaxis.pptxAntibiotic prophylaxis.pptx
Antibiotic prophylaxis.pptx
akramalsharaee1
 
fever in the postoperative period .ppt
fever in the postoperative period .pptfever in the postoperative period .ppt
fever in the postoperative period .ppt
SinzianaIonescu1
 
Acs0102 Infection Control In Surgical Practice
Acs0102 Infection Control In Surgical PracticeAcs0102 Infection Control In Surgical Practice
Acs0102 Infection Control In Surgical Practicemedbookonline
 
Infections In Immunecompromised Hosts Pocket ICU Medicine
Infections In Immunecompromised Hosts Pocket ICU MedicineInfections In Immunecompromised Hosts Pocket ICU Medicine
Infections In Immunecompromised Hosts Pocket ICU MedicineBassel Ericsoussi, MD
 
Preventing postoperative infection
Preventing postoperative infectionPreventing postoperative infection
Preventing postoperative infection
Chamika Huruggamuwa
 
Periprosthetic Joint Infection
Periprosthetic Joint InfectionPeriprosthetic Joint Infection
Periprosthetic Joint Infection
Dr. Bushu Harna
 
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNITBACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
JohannaLomuljo1
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissue
MOHAMMAD NOUR AL SAEED
 
Hospital acquired infection
Hospital acquired     infectionHospital acquired     infection
Hospital acquired infectionKashif Khokhar
 
Idsa guidelines
Idsa guidelinesIdsa guidelines
Idsa guidelines
Deepika Malik
 
pRiFUmeELGMEbKgY116.pptx
pRiFUmeELGMEbKgY116.pptxpRiFUmeELGMEbKgY116.pptx
pRiFUmeELGMEbKgY116.pptx
IbrahemIssacGaied
 
Surgical Site Infections Prophylaxis
Surgical Site Infections ProphylaxisSurgical Site Infections Prophylaxis
Surgical Site Infections Prophylaxis
Kishor Chand
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
Abdullatif Al-Rashed
 
Ventilator associated infections VAP
Ventilator associated infections VAP Ventilator associated infections VAP
Ventilator associated infections VAP
Thair Abuaqeel
 
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...Charles Harless, MPH, SASM, POPM
 

Similar to perioperative infection control.pptx (20)

SURGICAL SITE INFECTION (SSI)
SURGICAL SITE INFECTION (SSI)SURGICAL SITE INFECTION (SSI)
SURGICAL SITE INFECTION (SSI)
 
Immunopatologi Sepsis
Immunopatologi SepsisImmunopatologi Sepsis
Immunopatologi Sepsis
 
Antibiotic prophylaxis.pptx
Antibiotic prophylaxis.pptxAntibiotic prophylaxis.pptx
Antibiotic prophylaxis.pptx
 
fever in the postoperative period .ppt
fever in the postoperative period .pptfever in the postoperative period .ppt
fever in the postoperative period .ppt
 
Acs0102 Infection Control In Surgical Practice
Acs0102 Infection Control In Surgical PracticeAcs0102 Infection Control In Surgical Practice
Acs0102 Infection Control In Surgical Practice
 
THE IDEAL SURGICAL SUTURE
THE IDEAL SURGICAL SUTURE THE IDEAL SURGICAL SUTURE
THE IDEAL SURGICAL SUTURE
 
Infections In Immunecompromised Hosts Pocket ICU Medicine
Infections In Immunecompromised Hosts Pocket ICU MedicineInfections In Immunecompromised Hosts Pocket ICU Medicine
Infections In Immunecompromised Hosts Pocket ICU Medicine
 
Preventing postoperative infection
Preventing postoperative infectionPreventing postoperative infection
Preventing postoperative infection
 
Periprosthetic Joint Infection
Periprosthetic Joint InfectionPeriprosthetic Joint Infection
Periprosthetic Joint Infection
 
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNITBACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
BACTERIAL SEPSIS AT THE PEDATRIC INTENSIVE CARE UNIT
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissue
 
Hospital acquired infection
Hospital acquired     infectionHospital acquired     infection
Hospital acquired infection
 
Acs9905
Acs9905Acs9905
Acs9905
 
SSI -final
SSI -finalSSI -final
SSI -final
 
Idsa guidelines
Idsa guidelinesIdsa guidelines
Idsa guidelines
 
pRiFUmeELGMEbKgY116.pptx
pRiFUmeELGMEbKgY116.pptxpRiFUmeELGMEbKgY116.pptx
pRiFUmeELGMEbKgY116.pptx
 
Surgical Site Infections Prophylaxis
Surgical Site Infections ProphylaxisSurgical Site Infections Prophylaxis
Surgical Site Infections Prophylaxis
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
 
Ventilator associated infections VAP
Ventilator associated infections VAP Ventilator associated infections VAP
Ventilator associated infections VAP
 
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...
What is the Rate of Antibiotic Prescribing by Emergency Department Providers ...
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 

perioperative infection control.pptx

  • 1. Perioperative infection control and wound healing: Role of anesthesiologist Moderator Dr. Nishkarsh Gupta Dr. Hitender Gautam Additional Professor Associate Professor Deptt. of OAPM Deptt. of Microbiology Dr. Brajesh Ratre Assistant Professor Deptt. of OAPM Presenter- Dr. Gitartha Goswami SR, Deptt. of OAPM Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 2. Highlights • Epidemiology • Pathophysiology • SSIs and Wound infection • Microbiology • Risk factors • Role of anesthesiologists • Guidelines and evidences Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 3. Epidemiology • Incidence of HCAI- developed countries- 3.5–12%, developing countries- 5.7%- 19.1%. • The risk of HCAI in the OR is even higher. • SSIs- 2nd most common cause of HCAIs after UTI, account for approximately 17% of all HCAI. • SSIs are the most common perioperative infection, 38% of all infections in surgical patients • Prolongs hospital stay, cause morbidity, increase the cost of health care, and lead to mortality Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 4. Pathophysiology • Tissue damage leads to the release of damage activated molecular patterns (DAMPs) or alarmins into the circulation, eg- HMGB 1, mtDNA • DAMPs activates pattern recognition receptors (PRRs), also independently activate complement, neutrophils, monocytes and dendritic cells. • Activation of PRRs → secretion of cytokines and chemokines via signalling pathways involving NF-kB. • Excess production of inflammatory mediators (ILs) leads to SIRS. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 5. Pathophysiology • SIRS is associated with a compensatory increase in anti-inflammatory cytokines (IL-10, TGF-β). • The balance of proinflammatory (IL-6, TNF-a) and antiinflammatory factors dictates whether inflammation return to baseline or progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS). • PICS increases risk of MODS and sepsis. • Paradoxically, SIRS suppresses body’s ability to mount a defence against invading pathogens. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 6. Pathophysiology • Increased susceptibility to infection and sepsis, invading microbes further stimulate immune cells via pathogen-associated molecular patterns (PAMPs). • A vicious cycle ensues, SIRS results in inflammation and immunoparesis, which, in turn, leads to sepsis with furthur inflammation and risk of MODS. • The initial complement activation leads to consumption of complement, an imbalance ensues, rendering the host susceptible to invading pathogens. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 7. Pathophysiology • The transfusion of blood and products along with anesthetics contribute to this immunosuppressive environment. • Anaesthesia suppresses the immune system, both directly and indirectly. • Cancer recurrence and infection are intimately linked, both flourish in an environment of T-cell exhaustion and lymphocyte anergy, observed in the perioperative period. • The key concern is the creation of a protumour and proinfection cytokine and inflammatory milieu. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 8. Pathophysiology • Natural killer cells, are suppressed by both anaesthetics and opioids. • Anaesthetics mediate secondary effects through altered adrenocortical function. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 9. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 10. SSIs • CDC defines SSI- infection related to an operative procedure that occurs at or near the surgical incision within 30 days of the procedure or within 90 days if prosthetic material is implanted. • All surgical wounds are likely to become contaminated, usually by resident bacterial flora. • May not be significant and contaminated wounds may go unnoticed. • Progression from wound contamination to clinical infection is determined by the adequacy of host defence. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 11. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS 8-10% 12-20% 25% Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 12. SSIs types Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 13. SSIs types Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 14. MICROBIOLOGY • Pathogens depend upon the type of wound • Clean procedures- skin flora, including streptococcal species, Staphylococcus aureus, and CONS. • Clean-contaminated procedures- gram-negative and enterococci in addition to skin flora. • Surgical procedure involves a viscus, the pathogens reflect the endogenous flora of the viscus or nearby mucosal surface; typically polymicrobial. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 15. MICROBIOLOGY • The causative pathogens associated with SSIs have changed over time. • SSIs caused by gram-negative bacilli decreased, with emergence MRSA. • MRSA associated were higher mortality rates, longer hospital stays, and higher costs. • During the past decade the proportion of SSI due to MRSA declined. • Fungal SSIs- widespread use of prophylactic and empiric antibiotics, increased severity of illness, and immunocompromised patients. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 16. MICROBIOLOGY • Exogenous sources of contamination- OR environment or personnel. • Anal, vaginal, or nasopharyngeal carrier of group A streptococci by OR personnel, led to several SSI outbreaks. • Gram-negative organisms is commonly seen on the hands with artificial nails. • Rare outbreaks or clusters of SSIs caused by unusual pathogen- traced to contaminated dressings, bandages, irrigants, or disinfection solution Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 17. RISK FACTORS FOR SSI Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 18. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 19. Why cancer patients are at increased risk? • Effects of Cancer - Impaired cellular and humoral immunity - Bone marrow infiltration • Effects of CT/RT - Disruption of skin and mucosal barriers - Neutropenia/impaired neutrophil function • Functional hyposplenism or asplenia after HSCT • Poor nutritional status, TPN Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 20. What is the role of anesthesiolgist? • Role both outside and inside the OR. • Infection prevention in the OR anesthesia work area is important but very challenging owing to the work flow of anesthesia providers. • Policies and procedures for HH, safe injection practises, and environmental cleaning and disinfection. • Individuals involved in these procedures require training, as well as regular skills assessments. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 21. Factors controlled by anesthetists  Hand hygiene  Aseptic technique during invasive procedures  Face masks and sterile barriers  OR characteristics- Limit traffic through operating room, Use of laminar airflow  Surgical antibiotic prophylaxis  Glycaemic control  Perioperative thermoregulation Perioperative drugs management  Inspired oxygen concentration  Perioperative fluid management  Minimizing blood transfusions  ERAS Nutrition  Anesthetic technique - Avoidance of selected drugs - Regional anaesthesia techniques - Effect of PPV Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 22. Factors controlled by Surgeon and Surgical techniques 1. Skin antisepsis, Hair removal 2. Bowel preparation 3. Gentle traction 4. Effective hemostasis 5. Removal of devitalized tissues 6. Minimization of electrocautery to avoid thermal spread 7. Obliteration of dead space 8. Irrigation of tissues with saline to avoid excessive drying 9. Wound closure without tension 10. Judicious use of closed suction drains 11. Topical and local antibiotic delivery 12. Antibiotic-impregnated implants, antibiotic sutures 13. Wound dressings, wound protectors Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine
  • 23. Guidelines • Several guidelines available regarding prevention of SSI- CDC, WHO, APSIC, IDSA, NICE. • SHEA Expert Guidance on Infection prevention in the operating room anesthesia work area. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 24. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 25. Infection prevention in the OR anesthesia work area • Contamination in the anesthesia work area include the anesthesia cart, stopcocks, LMAs, laryngoscope blades, touchscreens, keyboards, providers’ hands. • Anesthesia work area bioburden- both commensal and pathogenic bacteria, including CONS, Bacillus spp, streptococci, Staph aureus, Acinetobacter spp etc. • High risk practises- use of multi-dose vials for >1 patient, <100% use of gloves during airway management, failure to perform HH after removing gloves, entry into anesthesia cart drawers without performance of HH. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 26. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 27. Hand hygiene • Ideally performed according to the WHO 5 Moments for Hand Hygiene. • HH performed- before aseptic tasks, after removing gloves, when hands are soiled or contaminated, before touching the contents of the anesthesia cart, and when entering and exiting the OR. • Indications in the OR can be as high as 54/hr, logistically unfeasible, leading to non adherence rates of 83%,. • Increasing access to ABHR led to an increase in HH practises by anesthesiology staff during a surgical procedure Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 28. Hand hygiene • ABHR dispensers at the entrances to ORs and near anesthesia providers. • Double gloves during airway management, removal of outer gloves immediately after airway manipulation and inner gloves ASAP and perform HH. • Current data inadequate to either support or discourage use of ABHR on gloved hands, application might be better when doffing and donning are not feasible Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 29. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 30. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 31. ASEPTIC PRECAUTIONS FOR VARIOUS PROCEDURES AND USE OF PPE • Objective- reduce endogenous and exogenous sources of infection to patients and HCWs. • Indications for aseptic practices- 1. During care and nursing of patients : Barrier nursing 2. During therapeutic procedures: i.m. injections, CVP line access, Arterial lines. 3. During airway and endoscopic procedures: Intubation, mechanical ventilation, suctioning, Bronchoscopy. 4. During various diagnostic procedures 5. Others- foley’s catheterization. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 32. USE OF PERSONAL PROTECTIVE EQUIPMENT • Use of PPE appropriate for the procedure. • PPE interrupt the chain of transmission of organisms from the patient to the HCW and from the HCW to the patient. • Correct donning and doffing practises. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 33. OR Environmental disinfection • Direct laryngoscope or video-laryngoscope handles and blades should undergo high-level disinfection or sterilization prior to use. • Otherwise, replace with single-use ones. • Clean blades and handles to be stored in packaging appropriate for semicritical items. • Infectious disease outbreaks have been associated with contaminated laryngoscopes. • Laryngoscope handles not able to undergo high-level disinfection should not be used. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 34. OR Environmental disinfection • Inadequate data to make recommendations regarding the use of disposable covers to prevent contamination of anesthesia machines. • High-touch surfaces on the anesthesia machine and anesthesia work area should be disinfected between OR uses. • Use EPA-approved hospital disinfectant that is compatible with the equipment and surfaces. • Reusable monitoring equipment and cables in physical contact with patients should be cleaned. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 35. OR Environmental disinfection • i.v. access ports- disinfected before each use, scrubbing the port with a sterile alcohol-based disinfectant or use sterile isopropyl alcohol containing caps to cover ports continuously. • The act can be challenging in anesthesia practice, particularly during induction and emergence of anesthesia. • Maximal sterile barrier precautions- All CVCs and axillary and femoral arterial lines. • Other peripheral arterial lines- a minimum of a cap, mask, sterile gloves, and a small sterile fenestrated drape. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 36. OR Environmental disinfection • Rubber stoppers of vials and necks of ampules- wiped with 70% alcohol prior to use. • Bacterial contamination of medication syringes can occur with skin microorganisms. • Needleless syringes should be capped with a sterile cap that completely covers the Luer connector on the syringe • Storage of supplies on the top surface of the cart should be avoided, should be removed between cases to facilitate cleaning. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 37. OR Environmental disinfection • Provider-prepared sterile injectable drugs should be used as soon as practicable, USP recommends use within 1hr • Commercially prefilled syringes or syringes prepared by the hospital pharmacy have a relatively long life. • Discard provider-prepared sterile injectable drugs and i.v. solutions at the end of each case, whether used or not. • Unused prefilled syringes with intact locks can be returned to stock. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 38. OR Environmental disinfection • Use Single-dose medication vials and flushes whenever possible. • Multi-dose vials- used for only 1 patient and accessed with a new sterile syringe and needle for each entry. • Syringes and needles are single patient devices and should never be reused for another patient. • Both CDC and AAGBI have issued safe injection practices. • Minimize the time between spiking IV bags and patient administration. • No specific time limit has been identified in the literature. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 39. OR Environmental disinfection • Computer keyboards and touchscreen- cleaned and disinfected after each anesthesia case using a hospital-approved disinfectant. • Use of Plastic keyboard shields, or washable keyboards and touchscreens facilitate thorough disinfection. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 40. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 41. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 42. OR ventilation • Laminar flow allows particle-free air movement over the aseptic operating field at a uniform velocity (vertically or horizontally). • Reduces the burden of microorganisms in the OR during implantation of prosthetic material • However, insufficient evidence supporting its routine use • A systematic review that included 12 observational studies (between 1987 and 2011) did not find any benefit in reducing the incidence of deep incisional SSI following hip and knee arthroplasty, and abdominal/open vascular surgeries. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 43. Order of patients • Common routes for transmission of infection in the OR are airborne or fomite borne. • Accurate printed theatre lists to be available prior to the scheduled date. • ‘Dirty cases’ should be identified beforehand, theatre staffs notified and scheduled last on an operating list. • If not possible, Hospital Infection Society advises that a plenum-ventilated OR should require a minimum of 15 min before proceeding to the next case. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 44. Order of patients • Appropriate cleaning of the OR between all patients should be undertaken. • Visible contamination with blood or body materials disinfected with sodium hypochlorite and then cleaned with detergent and water. • Floors of the OR should be disinfected at the end of each session. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 45. Implementation • Regular monitoring and evaluation of infection prevention practices. • Use of measures to improve performance. • Both overt and covert observation of behaviors can improve practice. • Regular feedbacks, surveillance measures. • Interventions like checklists and simulation for education and evaluation of different aspects of anesthesia practice Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 46. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 47. Surgical antibiotic prophylaxis CDC WHO IDSA Timing In a way that bactericidal concentration of the agents is established in the serum and tissues when the incision is made within the 120 min before the incision, while considering the half-life of the antibiotic (cefazolin, penicillins) Within 1 hour, 2 hours for Vancomycin and Fluoroquin. Repeat doses No statement At intervals of 2 half- lives or if there is excessive blood loss At intervals of 2 half-lives • Postoperatively, CDC recommends antibiotic therapy to continue only in contaminated and dirty cases. • Antibiotic stewardship programmes should be practised. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 48. Glycaemic control • Surgery causes a neuroendocrine stress response with release of counter- regulatory hormones (Epi, glucagon, cortisol, GH). • Hyperglycaemia increases risk of morbidity and mortality, even in non- diabetics. • DM increases susceptibility to infection by altering both the innate and the adaptive immune systems • Hyperglycaemia reduces vasodilation, impairs endothelial nitric oxide generation, decreases complement function, impairs neutrophil chemotaxis and phagocytosis. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 49. Glycaemic control • Nonenzymatic glycosylation of Ig, reducing complement fixation and opsonization of microbes. • Short-term hyperglycemia increases oxidative stress and systemic inflammatory responses. • Also impairs CD8+ T cell mediated immunity. • Hyperglycaemia alters the critical balance between inflammatory and antiinflammatory cytokines; increase adverse outcomes. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 50. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 51. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 52. Glycaemic targets • CDC guidelines advise perioperative glycemic control, and blood glucose target levels <200 mg/dL in patients with and without DM to prevent SSIs. • NICE-SUGAR trial demonstrates conventional glucose control (target of 180 mg/dL) had better outcomes (less mortality) than patients managed with intensive glucose control (target of 81–108 mg/dL). Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 53. Perioperative thermoregulation • Mild perioperative hypothermia (34°–36°C) is common in surgical patients. • Heat loss during the first hour of anesthesia- redistribution of core to peripheral temperature gradients caused by an anesthetic-induced vasodliation. • Causes of continued heat loss in the OR are radiation and convection. • The most effective means of preventing ongoing heat loss are forced air warming and administration of warmed fluids. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 54. Perioperative thermoregulation • Complications- increased LOS, increased intraoperative blood loss, transfusion requirements, adverse cardiac events • Mild hypothermia also increases incidence of SSIs. • Hypothermia triggers thermoregulatory vasoconstriction, thereby decreasing subcutaneous tissue oxygen tension • The major relation between hypothermia and increased SSI. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 55. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 56. Preop. temp Management <36°C Active warming in ward >/=36°C Active warming at least 30 minutes before induction Begin induction only when temperature is 36.0°C or above Active warming throughout the intraoperative phase if- having anaesthesia for more than 30 minutes or less than 30 minutes and are at higher risk of inadvertent perioperative hypothermia Introp. temp Maintain at >/= 36.5°C Postop. temp <36°C Warmed using forced-air warming until comfortably warm NICE guidelines
  • 57. SSIs risk with FAW devices • The waste air from FAW is not simply benign waste air. • The waste heat and air escapes from under the surgical drape near the floor, where it warms the contaminated air near the floor. • The contaminated warm air forms convection currents that rise along the sides of the surgical table • It mobilizes the floor bacteria into the sterile surgical field above the patient. • Studies have shown mixed results, larger RCTs needed. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 58. Perioperative drug management • Immunosuppressive agents like glucocorticoids, MTX, AZT, cyclosporine, and tacrolimus. • Glucocorticoids- major concerns are: (1) the risk of SSIs and (2) the risk of hemodynamic instability (secondary adrenal insufficiency). • Ideally, the lowest possible dose of glucocorticoids should be used in the perioperative setting. • If patients require >10 mg prednisone (or equivalent) daily, it implies that the disease activity is not adequately controlled and that elective surgery should be postponed. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 59. Perioperative drug management • Stopping DMARDs prior to surgery may result in a flare-up of disease activity, may adversely affect rehabilitation. • Biologic DMARDs can be continued till day of surgery. • Non- biologic DMRDs- Stop for atleast 2 weeks each for etanercept and adalimumab while 6 months for rituximab before elective surgery Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 60. Inspired oxygen concentration • Postulated to improve the oxidative bactericidal activity of neutrophils. • Adequate wound PO2 also helps in the development of collagen and epithelium, instrumental factors in wound healing. • Evidence that giving 80% FIO2 rather than 30% reduces wound infections in colorectal surgeries. • In vitro analysis of neutrophil function reveals that a higher PO2 promotes the production of reactive oxygen intermediates. • Current guidelines to prevent SSIs recommend only giving the required FIO2 to maintain oxygen saturations above 95%. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 61. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 62. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 63. Perioperative fluid management • Wound healing is critically dependent on adequate perfusion to deliver oxygen. • Mild to moderate hypovolemia is well tolerated as interstitial fluid moves into the intravascular space to preserve cardiac output. • However, this leaves the subcutaneous tissue relatively hypovolemic. • The optimal type of fluid (colloid or crystalloid) or strategy of fluid management (goal directed, liberal, or restrictive) remain controversial. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 64. Perioperative fluid management • Difficult to assess volume status in both liberal and restrictive strategy • GDFT has gained evidence for improved outcomes, does not specifically relate to a reduction in postoperative infection. • WHO recommednations (2016) on prevention of SSIs- GDFT in intraop. and postop. period is associated with decreased incidence of SSIs. • However, restrictive therapy and preoperative GDFT were not associated with reduction of SSI compared with standard therapy. • When considering SSIs as endpoint, GDFT may be considered if available. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 65. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 66. Minimizing blood transfusions • Immunomodulation and immunosuppression (TRIM) are known consequences of allogeneic blood transfusion. • The incidence of postoperative bacterial infection is higher in transfused patients. • This effect is greater in trauma patients- established fact. • The effect appears to be dose-related, older units (>2weeks) • Consider risk benefit ratios before transfusion, use fresh units. • Platelet transfusions are associated with bacterial sepsis. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 67. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 68. Enhanced recovery after surgery (ERAS) • Initiated by Professor Henrik Kehlet in the 1990s • ERAS or enhanced recovery programs (ERPs) or fast-tracking. • Initially started for colorectal surgeries, aim to achieve early recovery after surgery by maintaining preoperative organ function and reducing the surgical stress response. • Implemented in other surgeries and has shown a decrease in the incidence of HAIs. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 69. ERAS • Goals- maintenance of normal physiology in the perioperative period, decreasing surgical stress. • Key principles of the ERAS protocol  pre-operative counselling  preoperative nutrition  avoidance of prolonged perioperative fasting and carbohydrate loading up to 2 hours preoperatively  standardized anesthetic and analgesic regimens  early mobilization Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 70. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 71. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 72. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 73. Nutrition • Malnutrition is associated with a number of negative consequences  Increased susceptibility to infection  Poor wound healing  Increased frequency of decubitus ulcers  Overgrowth of bacteria in the gastrointestinal tract  Abnormal nutrient losses through the stool • Malnutrition leads to immune system dysfunction by impairing complement activation, bacterial opsonization, and the function of neutrophils, macrophages, and lymphocytes Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 74. Preoperative nutrition support • Adequately nourished or mild-to-moderate malnutrition, surgery need not be delayed for preoperative parenteral or enteral supplementation. • Patients with severe malnutrition- some benefit from delaying surgery to be fed only if catabolism is not due to the disease itself. • Benefit more from enteral than parenteral feeding; TPN increases risk for infectious complications. • However, parenteral nutrition was found beneficial in patients with upper gastrointestinal malignancies and hepatocellular carcinoma. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 75. Postperative nutrition support • Enteral nutrition (oral or tube feeds) rather than parenteral, whenever possible. • Postoperative parenteral nutrition-if return of bowel function is not anticipated for more than 10 days, severe malnutrition at baseline, or who have a complicated postoperative course. • Role for immune-enhancing nutritional supplements(arginine, glutamine, nonessential fatty acids, branched chain fatty acids), remains unclear. • There is insufficient high-quality evidence. Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 76. Decrease in infectious comlications including pneumonia, sepsis, wound infection, UTI etc were seen A 45% reduction on both infectious and non infectious complications were seen. Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 77. Anesthetic technique • Anaesthetic agents – Iv agents – Inhalational agents – Opioids • The role of Regional anesthesia • Effect of Positive pressure ventilation. • Several literature on association of anesthetic technique on cancer recurrence. • Perioperative events leading to cancer recurrence may be intimately related to perioperative infections. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 78. Agent NK cell no./activity T-lymphocyte Others Propofol Increase Do not inhibit Antioxidant effect Ketamine/ Thiopentone / Etomidate Decrease Decrease T helper cells Midazolam - - inhibitory efect on innate immunity, inhibit neutrophil adhesion by inhibiting the level of IL-8 Volatile anesthetics Decrease Decrease T helper cell activity Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 79. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 80. Agent NK cell no./activity T-lymphocyte Others Morphine suppresses NK cell activity Suppresses T-cell differentiation, promotes lymphocyte apoptosis Inhibit macrophage activity Fentanyl Decrease Increase regulatory T cells Sufentanil Decrease Increase regulatory T cells Inhibits leukocyte migration Tramadol May have protective effects on cellular immunity NSAIDs Reverses NK cell suppression Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 81. Role of regional anesthesia • Reduces perioperative stress response. • Serum levels of the stress hormone cortisol are lower. • Reducing the need for opioids or volatile anesthetics, • Orthopedic knee surgery conducted under neuraxial anesthesia led to a significant lower postoperative infections compared with general anesthesia. • A reduced duration of T-cell anergy and disturbances in T lymphocyte subsets (Th1 and 2) • However, high-quality evidence is lacking. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 82. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 83. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS
  • 84. Effect of Positive pressure ventilation • Positive pressure ventilation appears to impair mucociliary motility in the airways. • Stress and shear forces exerted during the cyclic opening and closing of alveoli result in increased cytokine production and white cell sequestration, as does over-distension of alveoli • PPV induce inflammation, decrease surfactant production, VILI. • May promote translocation of tracheal bacteria into the bloodstream. • ETT can serve as a conduit between the environment and LRT. Department of Onco-Anaesthesia and Palliative Medicine IRCH, National Cancer Institute, AIIMS Department of Onco-Anaesthesia and Palliative Medicine IRCH, NCI, AIIMS

Editor's Notes

  1. EPA- environmental protection agency, US